Active Ingredients in Trimo-San Vaginal Jelly
Trimo-San is a deodorant vaginal gel that does not contain traditional antimicrobial active pharmaceutical ingredients; instead, it functions as an acidifying and lubricating agent designed to restore and maintain normal vaginal pH. 1
Product Classification and Mechanism
Trimo-San is marketed as a vaginal acidifying gel rather than a therapeutic antimicrobial agent, with its primary mechanism being pH restoration to help reduce odor-causing bacteria that flourish in abnormal vaginal pH environments. 1
The product is specifically indicated for pessary wearers to help maintain the normal acidic pH of the vagina, as a pessary is considered a foreign body that can disrupt the vaginal environment. 1
The formulation creates a lubricating film that coats the vaginal walls, which may help reduce bacterial overgrowth by maintaining an acidic environment rather than through direct antimicrobial action. 1
Research Evidence on Antimicrobial Effects
In vitro studies demonstrate that Trimo-San significantly inhibits growth of both laboratory and clinical strains of Escherichia coli (P < 0.02), suggesting some antimicrobial properties beyond simple pH modification. 2
Trimo-San also significantly inhibits growth of Lactobacillus crispatus (P < 0.01), which is a potential concern since lactobacilli are protective commensal organisms essential for vaginal health. 2
The inhibitory effects on E. coli are eliminated when vaginal epithelial cells are present in co-culture, indicating that the in vitro antimicrobial activity may not fully translate to clinical efficacy in the vaginal environment. 2
Clinical Context and Limitations
Trimo-San is not listed among CDC-recommended regimens for bacterial vaginosis, vulvovaginal candidiasis, or trichomoniasis, and should not be used as a substitute for evidence-based antimicrobial therapy for these conditions. 3, 4, 3, 5
The product's inhibition of protective lactobacilli raises concerns about potential disruption of the normal vaginal microbiome, which could theoretically increase susceptibility to pathogenic infections despite its acidifying properties. 2
For pessary users with bacterial vaginosis, standard antimicrobial therapy (oral metronidazole 500 mg twice daily for 7 days) remains effective without requiring pessary removal, making Trimo-San unnecessary for infection treatment. 6